Trial Search Results

Thromboelastography in Non-elective Cesarean Delivery

The purpose of the study is to assess the coagulation changes that occur in laboring patients undergoing non-elective (intrapartum)Cesarean delivery using thromboelastography (TEG). We will compare coagulation data to assess potential coagulation changes associated with hemoglobin changes before and after surgery, and related to estimated blood loss.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Obstetric in-patients

   - Laboring patients with Epidurals for Labor Analgesia going for non-elective Cesarean

   - Patients of all ethnic backgrounds will be included

   - Singleton pregnancy

   - ASA 1 or 2

Exclusion Criteria:

   - Patients with underlying coagulation disorders.

   - Patients with thrombocytopenia (platelet count <100).

   - Patients with pregnancy-induced hypertension, pre-eclampsia.

   - Patients requiring the following medications prior to surgery: NSAIDS, aspirin,
   anticoagulants.

   - Patients requiring elective Cesarean delivery.

   - Patients with significant obstetric or medical disease.

   - No patients <18 years of age will be recruited.

Ages Eligible for Study

18 Years - 40 Years

Genders Eligible for Study

Female

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Alexander J Butwick, MBBS, FRCA
6507368513
Not Recruiting